OKYO Pharma Chairman Gabriele Cerrone Acquires Additional Shares, Strengthening Ownership To 29.12%
Portfolio Pulse from Benzinga Newsdesk
OKYO Pharma's Executive Chairman, Gabriele Cerrone, has increased his stake in the company by purchasing an additional 50,000 shares on NASDAQ at $1.03 each. This acquisition raises his total ownership to 29.12% of the company's issued share capital.

September 10, 2024 | 11:05 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Gabriele Cerrone, Executive Chairman of OKYO Pharma, has increased his ownership to 29.12% by purchasing 50,000 shares at $1.03 each. This move may signal confidence in the company's prospects.
The purchase of additional shares by the Executive Chairman is a strong indicator of insider confidence in the company's future performance. Such actions often lead to positive investor sentiment and can drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100